The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Same old same old people trying to create selling pressure in this thinly traded stock. It doesn't take much to move it. If even two people listen to the garbage being spun by the same people the stock price will move. Read between the lines! Red days like these are buy days. Adjust your investment horizon & short term expectations. This will fly on DHSC payment & in Q4 when covid is rife again (unfortunately).
The government has quietly altered its guidance for people in England trying to order free lateral flow tests more than a week earlier than planned in a bid to discourage the general public from competing with at-risk groups for limited supply.
Under the government’s “living with Covid” plan, the provision of free rapid tests for people in England was due to end on April 1. However, people trying to order lateral flow tests from the government’s ordering platform on Monday evening were informed that most people were no longer eligible to receive the tests.
“Most tests are now needed for people at higher risk in England,” the updated guidance said, adding that “most people without Covid-19 symptoms no longer need to take rapid lateral flow tests”.
It noted that eligibility had been restricted “to make sure tests are available for people who need them most”, including NHS workers, vulnerable individuals and those visiting high-risk settings.
One employee at the Department of Health told the Financial Times the guidance was changed early “to manage demand” and to prevent a “free-for-all” as people try to snap up tests before widescale free testing is wound down at the end of the month.
Another health official said the general public could still order tests but added that the limits on supply were designed to encourage non-vulnerable people to “question whether they need a test” or could “instead allow those in [at-risk] groups to order them as a priority”.
The plan to cut free, universal testing in England from the start of April has sparked criticism from experts who warn that it will make the pandemic more difficult to monitor and quicken the spread of the virus. It follows the end to legally-enforced self-isolation in England since late February.
In January when the Omicron variant was surging, around 300mn lateral flow tests were made available, but supply fell substantially in March, according to people familiar with the matter. Visitors to the government website have complained of struggling to access tests in recent days.
The UK is currently in the grip of a fresh outbreak of infections and hospitalisations, prompted by waning behavioural caution and the spread of the highly infectious Omicron BA.2 sub-variant, which is around 30 per cent more transmissible than Omicron BA.1.
Some 607,737 people tested positive for Covid across the UK in the week ending March 21, an increase of 37 per cent on the previous
This stock is still illiquid, and can be moved around easily. Double edged sword really, but hey ho.
The volume has been building most days (not-day-on-day, but reasonably convincing), however what is most interesting today is that the buys (currently) are at 24x the sells. As I'm sure people will know, this is reflected in the spread and the fact that it is hard to buy. As I mentioned yesterday, if we are lucky to get red days in the stock, buy it. 50p+ buy May 2022 and £1 min by Xmas. Crypto vol & upside without the regulatory risk! Love it.
Thanks, Dino4564. It looks good! Fingers crossed.
At these very low prices this is basically an accumulation period / zone; I am buying on every red day and accumulating shares.
Whatever the shorters or 'traders / spammers' are saying, if you just zoom out you'll be fine. Ignore the noise! There seems to be a lot of it!
I have high upside expectations for this stock, but I have a reasonable investment horizon (I can be flexible), subject to what happens c. 1 to 5 years.
I'm ok waiting for this one to hit a few £+.
I agree that expectation of timeframes should be longer here. It probably isn't all about Vatic and I doubt this will make the SP moon like people are hoping. But, if the trading update is positive (some of it maybe priced in a bit already) then it may go to placement price or near it?? I suspect that the main driver is the DHSC payment in May. If there is good news on this expect the SP to moon and then upwards in the run up to Xmas (covid) & beyond.
As alluded to, there a few on here, the same few people, who are pushing this stock around due to thin liquidity.
Look at the order flow below or go to tradingview for more detail. There are lots of strange orders when the stock falls on a day, which is pushing the price down due to think liquidity;
https://www.lse.co.uk/ShareTrades.asp?shareprice=ABDX&share=Abingdon-Healt
All it would take a a small amount of regular buys (on days like these) to equal up the buy / sell vol and it'd rise day-on-day pretty consistently.
It seems there are a lot more genuine investors than, cowboys. It is obvious to see who they are and it'd be easy to burn them... I'm watching closely now and so are others I see. Watch this space ....
People are playing the thin liquidity of this stock & as a result it is very easy to move. That is it, its not the end of the world, as every other post seems to want to suggest as they are playing games.
Simply, this stock is being targeted because of that. It isn't a big deal, it can work both ways and I have no doubts that it will do. This stock has crypto type vol, where the upside is much much larger now than the downside. Its a bet any rational person would be willing to take all day long, every day. ZOOM OUT.
Just topped up. Red days on this stock are a gift.
Here's something I posted a few days back to help others:
1/ ABDX tapped the market at the right time & are therefore well capitalised & have funding for an 2 year's without any new deals.
2/ They have set themselves up as OEM manufacturers for tests. This is a good plan & will likely work.
3/ If they do win new contracts, they'll be back in the blue almost immediately.
4/ Avacta may come back to the table.
5/ Vatic deal upside.
6/ They're building a B2C site which will generate sales & reduce reliance on flaky wholesale clients.
7/ They're awaiting (provisionally agreed) c. £8m + payment from the Government, where the hearing is in May 2022.
8/ They have had to be innovative due to very poor treatment by the Government & their clients & as an result they are now no longer reliant on Government contracts & have had to re-strategise. Where, there is no longer free testing anyway. They are ahead of the curve & this will work well in months & years to come.
9/ This is a mega growth sector. Bill Gates & Warren B have bought GAD in anticipation.
10/ Sadly, next Covid bout is coming. These stocks will be all the rage again soon.
11/ ABDX are diversifying & soon data from tests will be easily uploadable via QR codes, for example, to the NHS or GP for treatment to be sent to your home. Whether its Covid, Flu, lymes disease, HIV, etc etc. The home testing revolution is just starting now.
12/ There is a full reversal of globalisation going on infront of our eyes. Buying Chinese is not going to go down well here in blighty for much longer. Especially if they invade Taiwan. We all want to buy British, as long as its competitive & good quality.
13/ This stock is totally oversold. It should be trading around 50p+, if not for shortsellers. As a benchmark, how can ABDX be trading near ODX levels when ODX are barely just operating as a going concern. It's totally oversold.
14/ The board will likely time their news, once they've cleared their name in May.
15/ Max Duckworth is an investor. He's a known impact investor & holds c. 12 % holding in this firm.
16/ BoD heavily invested .
17/ Covid is coming back with a vengeance, sadly. https://youtu.be/yFUvv-Mmilg
I'm expecting a 10x + on this stock.
Wife / husband changing money to be had here.
Genuinely, it is a shame its all to do with covid, this stock is much more than a covid play, it about the emerging diagnostic vertical, but whatever the market wants, it gets.
Have a good day all.
https://youtu.be/yFUvv-Mmilg
I don't think they can afford to close our economy again, so it all points to testing. Plus strained relations with China.. plus this a hedge against the current market backdrop. Balls out, I'm guessing £1 min by Xmas. Ignore the noise, zoom out, SP is a gift currently.
https://youtu.be/yFUvv-Mmilg
Thanks for clarity, Bigjock36. ABDX has been ragged around due to illiquidity, but vol is building here and tide is changing. This SP is a gift (if you have funds to keep buying). I see people are still trading this short term and will keep selling out on good news & shorting, but atm as far as I can tell, these are chump change gains. This seems to be a great market hedge with loads of upside, in a tough market backdrop. Exciting stuff, although I'm not enamored about Covid hitting us hard again ...
I suspect these day-on day increases are 1/ due the new variant of Covid (this stock being traded as a Covid stock still) and 2/ resulting from leaked info on the Trading and Strategic update results due for release for the six months ended 31 Dec 2021 later this month. Perhaps we see a slow day-on-day increase (compounding can rebuild the SP quickly) for a month or two now until GLP trial in May; Subject to what happens and assuming ABDX clear their name and set precedent + a pay date, I suspect that's when we'll see the exponential gains on this one, as others have alluded to.
'Fear is the greatest illusion'... Zoom out & engage the little grey cells for fresh perspective.
Also, for the TA traders out there; We're seeing a trend reversal here. Higher lows and higher highs. Ascending triangle breakout. It's smashed the 3% upside. Buy the trend, & benefit from compounded gains on gains. The upside is huge on this one. The stock is dirt cheap still.
Morning all,
Imo, it is likely that the Ukraine war will end sooner than most think and then a mega rally in the market (c. Oct around US mid terms), then we will probably go into a recession and a nasty correction. Governments won't really be able to exercise QE as they have since 2009 as inflation is high and climbing. Most markets are going to fall and stay down for a few years after that. This stock however has a negative correlation to that market and I suspect that it will end up at at least £1 (min) to £2+ by Xmas 2022 when covid is rife again (sadly). Imo, early sellers who have been emotionally knocked by the major overselling in this misunderstood stock and being out of the money will lose out. Remember, this stock is being traded as a covid stock, currently. Once the Diagnostics market matures in the next 3 years+ or so. I expect this to be trading at around £3 to £5+, especially once institutional investors begin to invest. ADBX has set-up to manufacture for most vendors along with Surescreen (private co) and GAD (Bill Gates & Warren B).
Unless you are day trading or short term trading (there will be vol) it is probably worth holding this stock for wife changing money.
Good luck and happy thoughts to all human kind,
Jon
Its actually a quite alot higher % holding: He owns 7.59% via CatenaLucusvia & 6.39% via Thornapple, plus he subscribed c. 12% to the placement. He's a non exec Director now & advises the board.
https://www.lse.co.uk/rns/ABDX/result-of-placing-primarybid-and-subscription-5hmqqjljg9bm3ig.html
In addition, Max Duckworth is indirectly a substantial shareholder (as defined in the AIM Rules) in the Company and a former Director of the Company.
* Mr Duckworth's existing interests in Ordinary Shares are held via Thornapple LLP and CatenaLucis LLC, in which Mr Duckworth holds equity interests. CatenaLucis LLC and Thornapple LLP hold 7,266,264 Ordinary Shares (7.59% of the Company's current issued share capital) and 6,113,124 Ordinary Shares (6.39% of the Company's current issued share capital) respectively. Neither CatenaLucis LLC nor Thornapple LLP intend to take up their respective Open Offer Entitlements under the Open Offer.
Stocks like this can x5 to x10 in one session; Be patient & adjust your investment horizon. Zoom out. May / June 2022 & beyond, this will fly.
Reasons to buy this stock include;
1/ ABDX tapped the market at the right time & are therefore well capitalised & have funding for an 2 year's without any new deals.
2/ They have set themselves up as OEM manufacturers for tests. This is a good plan & will likely work.
3/ If they do win new contracts, they'll be back in the blue almost immediately.
4/ Avacta may come back to the table.
5/ Vatic deal upside.
6/ They're building a B2C site which will generate sales & reduce reliance on flaky wholesale clients.
7/ They're awaiting (provisionally agreed) c. £8m + payment from the Government, where the hearing is in May 2022.
8/ They have had to be innovative due to very poor treatment by the Government & their clients & as an result they are now no longer reliant on Government contracts & have had to re-strategise. Where, there is no longer free testing anyway. They are ahead of the curve & this will work well in months & years to come.
9/ This is a mega growth sector. Bill Gates & Warren B have bought GAD in anticipation.
11/ Sadly, next Covid bout is coming. These stocks will be all the rage again soon.
12/ ABDX are diversifying & soon data from tests will be easily uploadable via QR codes, for example, to the NHS or GP for treatment to be sent to your home. Whether its Covid, Flu, lymes disease, HIV, etc etc. The home testing revolution is just starting now.
13/ There is a full reversal of globalisation going on infront of our eyes. Buying Chinese is not going to go down well here in blighty for much longer. Especially if they invade Taiwan. We all want to buy British, as long as its competitive & good quality.
14/ This stock is totally oversold. It should be trading around 50p+, if not for shortsellers. As a benchmark, how can ABDX be trading near ODX levels when ODX are barely just operating as a going concern. It's totally oversold.
15/ The board will likely time their news, once they've cleared their name in May.
16/ Max Duckworth is an investor. He's a known impact investor & holds c. 12 % holding in this firm. He's not going to loose money & doesn't make many bad bets. BoD heavily invested too.
This one's a good one. It's just having a rough time atm, but this isca buying opportunity. The market is irrational.
GLA
Trader90 is another one posting negative trash talk to push the shareprice down. A part of the shorter gang I assume. Ask yourself, if Trader90 owned the stock why would 98% of his posts be so absolutely negative? Why would someone so deparately want the SP to go down if they are long the stock? They throw in a couple of curve balls every so often, to come across as authentic. Read between the lines. Use your in common sense & DYOR.
I don't normally post in chats tbh, I am a busy person. I simply jumped in here because I am fed up watching people like you & your mates talk utter trash, daily; Scaring ordinary people, preying on their emotions and pushing the stock price down because it is an easy target, losing people money and forcing them to sell in what is by all accounts (to anyone with a reasonable investment horizon) a promising stock in a potentially huge growing sector. I have seen that some people have invested considerable amounts of their savings here and are very upset. People like you prey on others fragile emotional state in a backdrop where it is easy to do so. This is not ok. To fellow investors, be patient on this one. I should think that the board will announce, when they can. They need to be paid by the DHSC first, most probably. I suspect we are at lows here, with some vol, in view of the back drop.